|
Index of reports
> Cases with Mouth Ulceration (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Leukeran (Chlorambucil) where reactions include mouth ulceration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Leukeran side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: female
Reactions: Mouth Ulceration, Hypophagia, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Matulane
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2012-01-06
Leukeran
Dosage: unk
Administration route: Oral
Start date: 2012-01-01
Velcade
Dosage: unk
Start date: 2012-01-01
Possible Leukeran side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02
Patient: female
Reactions: Dehydration, Hypophagia, Mouth Ulceration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: unk
Start date: 2012-01-01
Leukeran
Dosage: unk
Administration route: Oral
Start date: 2012-01-01
Matulane
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2012-01-06
Possible Leukeran side effects in 62 year old female
Reported by a physician from United States on 2012-02-10
Patient: 62 year old female
Reactions: Hypophagia, Dehydration, Mouth Ulceration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: iv
Indication: Hodgkin's Disease
Start date: 2012-01-01
Matulane
Dosage: 150 mg;qd;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2012-01-06
Leukeran
Dosage: po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2012-01-01
Possible Leukeran side effects in 48 year old female
Reported by a physician from United States on 2011-10-28
Patient: 48 year old female
Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure
Drug(s) suspected as cause:
Dapsone
Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
Indication: Behcet's Syndrome
Arava
Dosage: 20 mg daily
Indication: Behcet's Syndrome
Imuran
Dosage: titrated up to 150 mg daily
Indication: Behcet's Syndrome
Plaquenil
Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
Administration route: Oral
Indication: Behcet's Syndrome
Enbrel
Dosage: 25 mg twice weekly
Indication: Behcet's Syndrome
Methotrexate
Dosage: 7.5 mg per week, titrated up to 20 mg per week
Indication: Behcet's Syndrome
Cytoxan
Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
Indication: Behcet's Syndrome
Cyclosporine
Indication: Behcet's Syndrome
End date: 2001-01-06
Remicade
Dosage: 200 mg, 300 mg, 400 mg, intravenous
Indication: Behcet's Syndrome
Leukeran
Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
Indication: Behcet's Syndrome
Colchicine
Dosage: 6 mg twice daily, 6 mg twice daily
Indication: Behcet's Syndrome
Cellcept
Dosage: 1000 mg twice daily
Indication: Behcet's Syndrome
Rituxan
Dosage: 1000 mg, 1000 mg, intravenous
Indication: Behcet's Syndrome
End date: 2006-07-05
Prednisone
Dosage: 10 mg daily
Indication: Behcet's Syndrome
Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate
|
